🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
✕
Login
Home
News
Messages
Startup Showcase
Trackers
Premium
Premium Content
Jobs
Notifications
Settings
Try our Valuation Calculator →
Log In
News on Medial
The Covid Vaccine Windfall Turns on Pfizer and Moderna
Livemint
·
1y ago
Medial
The pandemic's decline in demand for Covid products has affected pharmaceutical giants Pfizer and Moderna. Pfizer's revenue has dropped by over 40%, resulting in layoffs and stock decline. Moderna has lost over $100 billion in market value and canceled combination vaccines for respiratory viruses. However, declining demand for Covid products is seen as a positive development, driving investment and research into other areas. The focus is shifting towards gene therapies for lifelong inherited diseases and personalized vaccines for cancer treatment. Obesity medications also show promise with significant benefits for patients.
View Source
Related News
Under RFK Jr., COVID shots will only be available to people 65+, high-risk groups
Arstechnica
·
2m ago
Medial
Under the leadership of Robert F. Kennedy Jr., the FDA is restricting access to COVID-19 vaccines, limiting them to individuals aged 65 and older and those with high-risk conditions. This decision bypasses usual advisory committee consultations. The new framework demands extensive trials for vaccine approval in healthy individuals under 65, posing challenges for vaccine manufacturers. Critics argue this approach echoes Kennedy's anti-vaccine stance and could impact public trust in vaccinations broadly.
View Source
No proof YouTube promoted anti-vaccine content amid Covid-19: Study
Economic Times
·
1y ago
Medial
A recent study published in the Journal of Medical Internet Research found no evidence that YouTube promoted anti-vaccine sentiment during the Covid-19 pandemic. The researchers examined YouTube's recommendation system and found that it did not lead users searching for vaccine-related videos to anti-vaccine content. The study analyzed over 27,000 video recommendations and concluded that YouTube's algorithms instead recommended other health-related content that was not explicitly related to vaccination.
View Source
Facebook failed to control Covid misinformation due to its design, reveals study
Economic Times
·
1y ago
Medial
A recent study revealed that Facebook's efforts to combat Covid-19 vaccine misinformation were ineffective due to the platform's design features. The study, conducted by researchers at George Washington University, found that simply removing content or changing algorithms is not enough to address misinformation. The design of the platform itself, which facilitates the spread of information based on users' interests, contributed to the continued engagement with anti-vaccine content. Additionally, the study highlighted the increase in misinformation on alternative social media platforms and the polarization of vaccine-related content on Facebook. The researchers suggested that platform designers collaborate to develop guidelines informed by scientific evidence to reduce online harms.
View Source
Pfizer helped save the world with covid vaccines. Now it needs to right itself.
Livemint
·
1y ago
Medial
Pfizer, once admired for its Covid-19 vaccines, is now facing a sharp decline in its fortunes. The company overestimated future demand for its pandemic products, leading to a drop in sales when the crisis subsided. Additionally, Pfizer's other products couldn't compensate for the decrease. The company's shares have hit a nine-year low, losing $140 billion in valuation. Pfizer is implementing cost-cutting measures, including layoffs, while launching new products and pursuing acquisitions. Its falling sales forecasts and disappointing study results have raised concerns among investors.
View Source
Pfizer CEO, Under Fire, Will Do ‘Whatever It Takes’ to Grow
Livemint
·
9m ago
Medial
Pfizer CEO, Albert Bourla, has stated that he is committed to growing the company's earnings per share (EPS) and is willing to make further cost cuts if necessary. This comes as the company faces criticism from activist investor, Starboard Value, over alleged mismanagement and underwhelming returns. Bourla's response includes emphasizing the company's cost-saving initiatives and defending their recent deal-making. Despite the criticism, Pfizer raised its guidance for the year following a strong third quarter boosted by sales of COVID-related products. The stock, however, saw a decline after the announcement.
View Source
Reinventing Serum
Business Today
·
2m ago
Medial
Serum Institute of India is evolving under Adar Poonawalla's leadership, shifting focus from Covid-19 vaccine supremacy to research-driven innovation and diverse investments. As pandemic revenues stabilize, SII is developing India's first indigenous HPV vaccine and pursuing US and EU regulatory approvals. The company also diversifies into diagnostics, financial services, and film production. This corporate reinvention mirrors broader industry changes, alongside insights into Pakistan's economic decline. The June 8 issue explores these themes extensively.
View Source
Smile Group appoints former AstraZeneca exec to lead healthtech venture studio
VCCircle
·
2m ago
Medial
Smile Group has appointed Gagandeep Singh Bedi, former AstraZeneca Pharma India MD, as managing partner to lead its new healthtech venture studio. Bedi brings 25 years of healthcare experience, having worked with firms like Boehringer Ingelheim and Eli Lilly. He significantly contributed to AstraZeneca India's growth and its COVID-19 vaccine response. Smile Group, focused on scaling ventures in high-growth markets, sees AI in healthcare as a booming $50 billion opportunity in APAC.
View Source
Mark Zuckerberg reveals Biden administration coerced Facebook into censoring content on Covid vaccine
Economic Times
·
7m ago
Medial
Meta CEO Mark Zuckerberg disclosed that the Biden administration pressured Facebook to censor content discussing Covid vaccines. Speaking on the Joe Rogan Podcast, Zuckerberg revealed that government officials insisted on removing posts suggesting vaccine side effects, which the platform resisted, as they were factual. He criticized the coercion, citing instances where Facebook was pressured to take down humorous or true content. In response to censorship concerns, Meta plans to adopt a user-driven "Community Notes" system.
View Source
Pfizer to invest ₹25 lakh each in six healthcare startups
Livemint
·
1y ago
Medial
Pharmaceutical company Pfizer is partnering with India's National Institute of Pharmaceutical Education & Research (NIPER) to support healthcare startups under the INDovation program. Six startups will be selected and incubated at NIPER with an investment of ₹25 lakh each. Pfizer will provide incubation support, including product development and regulatory pathway guidance. Startups focusing on deep tech and artificial intelligence in areas like predictive analysis, point-of-care testing, and informatics will be considered. Pfizer has already supported the funding and development of 34 startups through the INDovation initiative.
View Source
70% vaccines sourced by WHO, 14% generics imported by US are from India: Minister
Economic Times
·
1m ago
Medial
Union Minister Anupriya Patel highlighted India's significant role in global healthcare during a forum organized by the Indian Pharmacopoeia Commission. She noted that India supplies 70% of the World Health Organization's vaccines and 14% of the generic medicines imported by the US. Patel emphasized India's commitment to affordable, quality medicines, praising initiatives like Jan Aushadhi Kendras and the 'Vaccine Maitri' program, which distributed vaccines to over 100 countries during the COVID-19 pandemic.
View Source
Trackers
Active Indian VC’s
OG Capital
Email
With a hands-on approach, OG Capital aims to invest in over 20 promising...
Accel Partners
Email
Early and growth-stage investments in disruptive technology companies with...
Blume
Email
Early-stage venture capital firm investing in technology startups in India. Focus on...
Access All Trackers
Startup Showcase Winners
June 2025
Buddy
Helping your parents when you are miles away
BiteStop
The Pit Stop Your Cravings Deserve
Bloomer
The next generation E-commerce platform
Enter Ongoing Startup Showcase
Top Users
Trending News on Medial
Download the medial app to read full posts, comements and news.
Go to Medial App
Not Now
Know everything that’s happening in the startup ecosystem, first.
Enable Notifications?
No, thanks
Count me in
